Similar articles for PMID: 21873466

Year	Number of Results
2005	2
2006	3
2007	1
2008	7
2009	9
2010	12
2011	14
2012	14
2013	11
2014	9
2015	7
2016	4
2017	6
2018	2
2019	2
2021	2
2022	2
2023	1
2024	0

1

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3.

Thompson AJ, Patel K, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Rustgi VK, Flisiak R, Pianko S, Diago M, Arora S, Foster GR, Torbenson M, Benhamou Y, Nelson DR, Sulkowski MS, Zeuzem S, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-1 and ACHIEVE-2/3 Study Teams. Thompson AJ, et al. Gut. 2012 Jan;61(1):128-34. doi: 10.1136/gut.2010.236158. Epub 2011 Aug 26. Gut. 2012. PMID: 21873466 Free PMC article. Clinical Trial.

2

Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients.

Khattab M, Eslam M, Sharwae MA, Shatat M, Ali A, Hamdy L. Khattab M, et al. Am J Gastroenterol. 2010 Sep;105(9):1970-7. doi: 10.1038/ajg.2010.110. Epub 2010 Mar 16. Am J Gastroenterol. 2010. PMID: 20234345

3

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

Serfaty L, Forns X, Goeser T, Ferenci P, Nevens F, Carosi G, Drenth JP, Lonjon-Domanec I, DeMasi R, Picchio G, Beumont M, Marcellin P. Serfaty L, et al. Gut. 2012 Oct;61(10):1473-80. doi: 10.1136/gutjnl-2011-300749. Epub 2012 Mar 2. Gut. 2012. PMID: 22387529 Clinical Trial.

4

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

Jung HJ, Kim YS, Kim SG, Lee YN, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS. Jung HJ, et al. Clin Mol Hepatol. 2014 Mar;20(1):38-46. doi: 10.3350/cmh.2014.20.1.38. Epub 2014 Mar 26. Clin Mol Hepatol. 2014. PMID: 24757657 Free PMC article.

5

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.

Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Taniai H, Okada K, Kainuma M, Hayashi J. Ogawa E, et al. J Hepatol. 2012 Sep;57(3):534-40. doi: 10.1016/j.jhep.2012.04.027. Epub 2012 May 18. J Hepatol. 2012. PMID: 22613000

6

The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C.

Ziada DH, El Saadany S, Enaba M, Ghazy M, Hasan A. Ziada DH, et al. Can J Gastroenterol. 2012 Jun;26(6):325-9. doi: 10.1155/2012/291457. Can J Gastroenterol. 2012. PMID: 22720272 Free PMC article.

7

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.

Khattab MA, Eslam M, Shatat M, Abd-Aalhalim H, Mousa YI, Samir F, Aly H, Shaker O, Shaker Y. Khattab MA, et al. J Gastrointestin Liver Dis. 2012 Mar;21(1):59-65. J Gastrointestin Liver Dis. 2012. PMID: 22457861 Free article. Clinical Trial.

8

Meta-analysis: insulin resistance and sustained virological response in hepatitis C.

Eslam M, Aparcero R, Kawaguchi T, Del Campo JA, Sata M, Khattab MA, Romero-Gomez M. Eslam M, et al. Aliment Pharmacol Ther. 2011 Aug;34(3):297-305. doi: 10.1111/j.1365-2036.2011.04716.x. Epub 2011 May 29. Aliment Pharmacol Ther. 2011. PMID: 21623851 Free article.

9

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Nelson DR, Benhamou Y, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Flisiak R, Rasenack JW, Kryczka W, Lee CM, Bain VG, Pianko S, Patel K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-2/3 Study Team. Nelson DR, et al. Gastroenterology. 2010 Oct;139(4):1267-76. doi: 10.1053/j.gastro.2010.06.062. Epub 2010 Jul 1. Gastroenterology. 2010. PMID: 20600017 Free PMC article. Clinical Trial.

10

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.

Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Bair MJ. Cheng CH, et al. Front Endocrinol (Lausanne). 2022 Jan 13;12:799382. doi: 10.3389/fendo.2021.799382. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35095765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

95 results

Results by year